MM-161 Talquetamab + Daratumumab in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Updated TRIMM-2 Results
- Resource Type
- Abstract
- Authors
- Dholaria, Bhagirathbhai; Weisel, Katja; Mateos, Maria-Victoria; Goldschmidt, Harmut; Martin, Thomas; Morillo, Daniel; Reece, Donna; Rodriguez-Otero, Paula; Bhutani, Manisha; D'Souza, Anita; Oriol, Albert; Rosinol, Laura; Bahlis, Nizar; Bakshi, Kalpana; Kang, Lijuan; Vandenberk, Lien; Smit, M Damiette; Wasch, Ralph; van de Donk, Niels; Chari, Ajai
- Source
- In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S476-S477
- Subject
- Language
- ISSN
- 2152-2650